309 related articles for article (PubMed ID: 25627831)
1. Treatment of clozapine-associated weight gain: a systematic review.
Whitney Z; Procyshyn RM; Fredrikson DH; Barr AM
Eur J Clin Pharmacol; 2015 Apr; 71(4):389-401. PubMed ID: 25627831
[TBL] [Abstract][Full Text] [Related]
2. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
[TBL] [Abstract][Full Text] [Related]
3. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S
PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome.
Zimbron J; Khandaker GM; Toschi C; Jones PB; Fernandez-Egea E
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1353-1365. PubMed ID: 27496573
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
[TBL] [Abstract][Full Text] [Related]
6. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
7. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
8. Weight gain induced by clozapine.
Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
Eur Neuropsychopharmacol; 1995 Dec; 5(4):437-40. PubMed ID: 8998394
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
10. Weight gain among schizophrenic patients treated with clozapine.
Lamberti JS; Bellnier T; Schwarzkopf SB
Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
12. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
[TBL] [Abstract][Full Text] [Related]
13. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ellinger LK; Ipema HJ; Stachnik JM
Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
[TBL] [Abstract][Full Text] [Related]
15. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment.
Monteleone P; Fabrazzo M; Tortorella A; La Pia S; Maj M
J Clin Psychopharmacol; 2002 Aug; 22(4):424-6. PubMed ID: 12172344
[TBL] [Abstract][Full Text] [Related]
16. Weight gain associated with antipsychotic drugs.
Ganguli R
J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
[TBL] [Abstract][Full Text] [Related]
17. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of sex-based differences in effectiveness and adverse effects of clozapine.
Alberich S; Fernández-Sevillano J; González-Ortega I; Usall J; Sáenz M; González-Fraile E; González-Pinto A
Psychiatry Res; 2019 Oct; 280():112506. PubMed ID: 31401291
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.
Lu ML; Lane HY; Lin SK; Chen KP; Chang WH
J Clin Psychiatry; 2004 Jun; 65(6):766-71. PubMed ID: 15291653
[TBL] [Abstract][Full Text] [Related]
20. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]